* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 11200 | CHEK2 | C0029463 | Osteosarcoma | 0.603557092817453 | BEFREE;CTD_human;HPO;LHGDN;ORPHANET |
| 11200 | CHEK2 | C0085390 | Li-Fraumeni Syndrome | 0.410685633829676 | BEFREE;CTD_human;LHGDN;ORPHANET |
| 11200 | CHEK2 | C2931456 | Prostate cancer, familial | 0.400824180352639 | BEFREE;CTD_human;ORPHANET |
| 11200 | CHEK2 | C1836482 | Li-Fraumeni Syndrome 2 | 0.4 | CTD_human;UNIPROT |
| 11200 | CHEK2 | C0006142 | Malignant neoplasm of breast | 0.314890301595064 | BEFREE;GAD;UNIPROT |
| 11200 | CHEK2 | C1458155 | Mammary Neoplasms | 0.29210065515107 | BEFREE;CTD_human;GAD;LHGDN |
| 11200 | CHEK2 | C0678222 | Breast Carcinoma | 0.235714481947703 | BEFREE;HPO |
| 11200 | CHEK2 | C0033578 | Prostatic Neoplasms | 0.224493897868698 | BEFREE;CTD_human;GAD;LHGDN |
| 11200 | CHEK2 | C0009404 | Colorectal Neoplasms | 0.221537415776984 | CTD_human;GAD;LHGDN |
| 11200 | CHEK2 | C0376358 | Malignant neoplasm of prostate | 0.218353858653341 | BEFREE;GAD;UNIPROT |
| 11200 | CHEK2 | C0030297 | Pancreatic Neoplasm | 0.209953998034678 | GAD;HPO;LHGDN |
| 11200 | CHEK2 | C0024121 | Lung Neoplasms | 0.207821696295603 | BEFREE;CTD_human;GAD;LHGDN |
| 11200 | CHEK2 | C0024299 | Lymphoma | 0.203831819601666 | BEFREE;HPO;LHGDN |
| 11200 | CHEK2 | C0017638 | Glioma | 0.20350593566014 | BEFREE;GAD;HPO |
| 11200 | CHEK2 | C0242788 | Breast Neoplasms, Male | 0.202732912464814 | CTD_human;LHGDN |
| 11200 | CHEK2 | C0025286 | Meningioma | 0.202681755307501 | BEFREE;GAD;HPO |
| 11200 | CHEK2 | C0009375 | Colonic Neoplasms | 0.202681755307501 | BEFREE;GAD;HPO |
| 11200 | CHEK2 | C0699791 | Stomach Carcinoma | 0.201648360705279 | BEFREE;HPO |
| 11200 | CHEK2 | C0677776 | Hereditary Breast and Ovarian Cancer Syndrome | 0.201373633921065 | BEFREE;ORPHANET |
| 11200 | CHEK2 | C1261473 | Sarcoma | 0.200824180352639 | BEFREE;HPO |
| 11200 | CHEK2 | C0346647 | Malignant neoplasm of pancreas | 0.200549453568426 | BEFREE;HPO |
| 11200 | CHEK2 | C0024305 | Lymphoma, Non-Hodgkin | 0.200274726784213 | BEFREE;CTD_human |
| 11200 | CHEK2 | C0027819 | Neuroblastoma | 0.200274726784213 | BEFREE;CTD_human |
| 11200 | CHEK2 | C0035335 | Retinoblastoma | 0.200274726784213 | BEFREE;HPO |
| 11200 | CHEK2 | C0027766 | Nervous System Neoplasms | 0.2 | HPO |
| 11200 | CHEK2 | C0030193 | Pain | 0.2 | HPO |
| 11200 | CHEK2 | C0037286 | Skin Neoplasms | 0.2 | HPO |
| 11200 | CHEK2 | C0038356 | Stomach Neoplasms | 0.2 | CTD_human |
| 11200 | CHEK2 | C0152031 | Joint swelling | 0.2 | HPO |
| 11200 | CHEK2 | C0206720 | Squamous Cell Neoplasms | 0.2 | CTD_human |
| 11200 | CHEK2 | C0221204 | Lytic lesion | 0.2 | HPO |
| 11200 | CHEK2 | C0524801 | Retinal Neoplasms | 0.2 | HPO |
| 11200 | CHEK2 | C0750857 | Alkaline phosphatase serum increased | 0.2 | HPO |
| 11200 | CHEK2 | C1838578 | Encephalopathy, progressive | 0.2 | HPO |
| 11200 | CHEK2 | C1842408 | Increased risk of pancreatic cancer | 0.2 | HPO |
| 11200 | CHEK2 | C4021768 | Abnormality of metabolism/homeostasis | 0.2 | HPO |
| 11200 | CHEK2 | C4025038 | Abnormality of the tibial metaphysis | 0.2 | HPO |
| 11200 | CHEK2 | C4025040 | Abnormality of the femoral metaphysis | 0.2 | HPO |
| 11200 | CHEK2 | C4073168 | Abnormal lactate dehydrogenase activity | 0.2 | HPO |
| 11200 | CHEK2 | C4280444 | Abnormality of the wide portion of the femoral bone | 0.2 | HPO |
| 11200 | CHEK2 | C4280575 | Progressive brain disease | 0.2 | HPO |
| 11200 | CHEK2 | C0001618 | Tumors of Adrenal Cortex | 0.2 | HPO |
| 11200 | CHEK2 | C0007114 | Malignant neoplasm of skin | 0.2 | HPO |
| 11200 | CHEK2 | C1527249 | Colorectal Cancer | 0.0250254906547791 | BEFREE;GAD |
| 11200 | CHEK2 | C1140680 | Malignant neoplasm of ovary | 0.0136835033217186 | BEFREE;GAD |
| 11200 | CHEK2 | C0007137 | Squamous cell carcinoma | 0.0134599336948182 | BEFREE;GAD;LHGDN |
| 11200 | CHEK2 | C0242379 | Malignant neoplasm of lung | 0.0096936266277819 | BEFREE;GAD |
| 11200 | CHEK2 | C0919267 | ovarian neoplasm | 0.00837114986402905 | BEFREE;GAD;LHGDN |
| 11200 | CHEK2 | C0024667 | Animal Mammary Neoplasms | 0.007221085569864 | GAD |
| 11200 | CHEK2 | C0012860 | DNA Damage | 0.007221085569864 | GAD |
| 11200 | CHEK2 | C0023418 | leukemia | 0.0060152784980537 | BEFREE;LHGDN |
| 11200 | CHEK2 | C0600139 | Prostate carcinoma | 0.005494535684262 | BEFREE |
| 11200 | CHEK2 | C0009402 | Colorectal Carcinoma | 0.005494535684262 | BEFREE |
| 11200 | CHEK2 | C0346153 | Breast Cancer, Familial | 0.0052198089000489 | BEFREE |
| 11200 | CHEK2 | C0596263 | Carcinogenesis | 0.0046703553316227 | BEFREE |
| 11200 | CHEK2 | C0238033 | Carcinoma of Male Breast | 0.0037806624443535 | BEFREE;GAD |
| 11200 | CHEK2 | C0017636 | Glioblastoma | 0.00328236603323995 | BEFREE;LHGDN |
| 11200 | CHEK2 | C0206692 | Carcinoma, Lobular | 0.00300763924902685 | BEFREE;LHGDN |
| 11200 | CHEK2 | C0005695 | Bladder Neoplasm | 0.00300763924902685 | BEFREE;LHGDN |
| 11200 | CHEK2 | C0005859 | Bloom Syndrome | 0.00300763924902685 | BEFREE;LHGDN |
| 11200 | CHEK2 | C0476089 | Endometrial Carcinoma | 0.0029564820917142 | BEFREE;GAD |
| 11200 | CHEK2 | C0677886 | Epithelial ovarian cancer | 0.0029564820917142 | BEFREE;GAD |
| 11200 | CHEK2 | C0001418 | Adenocarcinoma | 0.0029564820917142 | BEFREE;GAD |
| 11200 | CHEK2 | C0684249 | Carcinoma of lung | 0.002747267842131 | BEFREE |
| 11200 | CHEK2 | C0004135 | Ataxia Telangiectasia | 0.002747267842131 | BEFREE |
| 11200 | CHEK2 | C0014170 | Endometrial Neoplasms | 0.00273291246481375 | LHGDN |
| 11200 | CHEK2 | C0027859 | Acoustic Neuroma | 0.0026817553075011 | BEFREE;GAD |
| 11200 | CHEK2 | C0005684 | Malignant neoplasm of urinary bladder | 0.0026817553075011 | BEFREE;GAD |
| 11200 | CHEK2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0026817553075011 | BEFREE;GAD |
| 11200 | CHEK2 | C0020538 | Hypertensive disease | 0.0026817553075011 | BEFREE;GAD |
| 11200 | CHEK2 | C0022658 | Kidney Diseases | 0.0026817553075011 | BEFREE;GAD |
| 11200 | CHEK2 | C0023434 | Chronic Lymphocytic Leukemia | 0.0026817553075011 | BEFREE;GAD |
| 11200 | CHEK2 | C1306460 | Primary malignant neoplasm of lung | 0.0024725410579179 | BEFREE |
| 11200 | CHEK2 | C0027663 | Neoplasms, Multiple Primary | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0546837 | Malignant neoplasm of esophagus | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0887833 | Carcinoma, Pancreatic Ductal | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0004153 | Atherosclerosis | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0004763 | Barrett Esophagus | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0006118 | Brain Neoplasms | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0007621 | Neoplastic Cell Transformation | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0014859 | Esophageal Neoplasms | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0018671 | Head and Neck Neoplasms | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0022665 | Kidney Neoplasm | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0023055 | Laryngeal neoplasm | 0.002407028523288 | GAD |
| 11200 | CHEK2 | C0029925 | Ovarian Carcinoma | 0.0021978142737048 | BEFREE |
| 11200 | CHEK2 | C0027627 | Neoplasm Metastasis | 0.0016483607052786 | BEFREE |
| 11200 | CHEK2 | C0242787 | Malignant neoplasm of male breast | 0.0016483607052786 | BEFREE |
| 11200 | CHEK2 | C0025202 | melanoma | 0.0013736339210655 | BEFREE |
| 11200 | CHEK2 | C0699790 | Colon Carcinoma | 0.0013736339210655 | BEFREE |
| 11200 | CHEK2 | C1096616 | contralateral breast cancer | 0.0013736339210655 | BEFREE |
| 11200 | CHEK2 | C0235653 | Malignant neoplasm of female breast | 0.0010989071368524 | BEFREE |
| 11200 | CHEK2 | C0238463 | Papillary thyroid carcinoma | 0.0010989071368524 | BEFREE |
| 11200 | CHEK2 | C3539878 | Triple Negative Breast Neoplasms | 0.0010989071368524 | BEFREE |
| 11200 | CHEK2 | C0007102 | Malignant tumor of colon | 0.0010989071368524 | BEFREE |
| 11200 | CHEK2 | C0007104 | Female Breast Carcinoma | 0.0010989071368524 | BEFREE |
| 11200 | CHEK2 | C0178874 | Tumor Progression | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C0235974 | Pancreatic carcinoma | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C0585442 | Osteosarcoma of bone | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C1336076 | Sporadic Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C0002395 | Alzheimer's Disease | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0008241803526393 | BEFREE |
| 11200 | CHEK2 | C0023487 | Acute Promyelocytic Leukemia | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0024623 | Malignant neoplasm of stomach | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0032580 | Adenomatous Polyposis Coli | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0278487 | Stage III Breast Cancer AJCC v6 | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0279626 | Squamous cell carcinoma of esophagus | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0280100 | solid tumor | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0398791 | Nijmegen Breakage Syndrome | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C1302401 | Adenoma of large intestine | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C1333990 | Hereditary Nonpolyposis Colorectal Cancer | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C1512981 | Mammary Tumorigenesis | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C1621958 | Glioblastoma Multiforme | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C1883486 | Uterine Corpus Cancer | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C2239176 | Liver carcinoma | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C3146271 | Stage III Breast Cancer AJCC v7 | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0007103 | Malignant neoplasm of endometrium | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0018801 | Heart failure | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0018802 | Congestive heart failure | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0019829 | Hodgkin Disease | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0023467 | Leukemia, Myelocytic, Acute | 0.0005494535684262 | BEFREE |
| 11200 | CHEK2 | C0023473 | Myeloid Leukemia, Chronic | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0023903 | Liver neoplasms | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0035412 | Rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0040028 | Thrombocythemia, Essential | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0079744 | Diffuse Large B-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0085183 | Neoplasms, Second Primary | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0149925 | Small cell carcinoma of lung | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0151468 | Thyroid Gland Follicular Adenoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0152136 | Low Tension Glaucoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0205647 | Follicular adenoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0205824 | Liposarcoma, Dedifferentiated | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0205851 | Germ cell tumor | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0206659 | Embryonal Carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0206682 | Follicular thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0206701 | Cystadenocarcinoma, Serous | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0238198 | Gastrointestinal Stromal Tumors | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0259785 | Malignant Meningioma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0278488 | Carcinoma breast stage IV | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0280785 | Diffuse Astrocytoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0281267 | bilateral breast cancer | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0346429 | Multiple malignancy | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0424295 | Hyperactive behavior | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0595921 | Intraocular pressure disorder | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0595989 | Carcinoma of larynx | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0598428 | genetic hypertension | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0685938 | Malignant neoplasm of gastrointestinal tract | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0699885 | Carcinoma of bladder | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0854778 | Resectable Pancreatic Carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0940937 | precancerous lesions | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C1168401 | Squamous cell carcinoma of the head and neck | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C1301034 | Pancreatic intraepithelial neoplasia | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C1333600 | Hereditary Malignant Neoplasm | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C1762616 | Meningioma, benign, no ICD-O subtype | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C1861906 | Breast Cancer, Familial Male | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C1862382 | SVEINSSON CHORIORETINAL ATROPHY | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C2347762 | Childhood Teratoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C2675080 | Li-Fraumeni-Like Syndrome | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C2931822 | Nasopharyngeal carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C2986665 | Early-Stage Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C3642345 | Luminal A Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C3642346 | Luminal B Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0003873 | Rheumatoid Arthritis | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0004134 | Ataxia | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0004277 | Tooth Attrition | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0007107 | Malignant neoplasm of larynx | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0007758 | Cerebellar Ataxia | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0010346 | Crohn Disease | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0010633 | Cystadenoma | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0010674 | Cystic Fibrosis | 0.0002747267842131 | BEFREE |
| 11200 | CHEK2 | C0020179 | Huntington Disease | 0.0002747267842131 | BEFREE |